Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies.
about
Activation of fast skeletal muscle troponin as a potential therapeutic approach for treating neuromuscular diseasesAutoimmune encephalopathies.Structural insights into the molecular mechanisms of myasthenia gravis and their therapeutic implications.Myasthenia gravis: further electrophysiological and ultrastructural analysis of transmission failure in the mouse passive transfer model.Acetylcholine receptors and myasthenia.Passive transfer of autoimmune autonomic neuropathy to mice.Immunization of rats with polypeptide chains from torpedo acetylcholine receptor causes an autoimmune response to receptors in rat muscle.Myasthenia gravis--current concepts.Regulation of acetylcholine receptor alpha subunit variants in human myasthenia gravis. Quantification of steady-state levels of messenger RNA in muscle biopsy using the polymerase chain reaction.The muscle cell.Tissue-specific antibodies in myasthenia gravis.Myasthenogenicity of the main immunogenic region and endogenous muscle nicotinic acetylcholine receptorsGuidelines for pre-clinical assessment of the acetylcholine receptor--specific passive transfer myasthenia gravis model-Recommendations for methods and experimental designsPhenotypic and functional characterization of T cells from patients with myasthenia gravis.The thymus in myasthenia gravis. Changes typical for the human disease are absent in experimental autoimmune myasthenia gravis of the Lewis rat.Autoreactive T Cells from Patients with Myasthenia Gravis Are Characterized by Elevated IL-17, IFN-γ, and GM-CSF and Diminished IL-10 Production.Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis.Monoclonal antibodies used to probe acetylcholine receptor structure: localization of the main immunogenic region and detection of similarities between subunits.Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental automimInhibitory effect of alpha-fetoprotein on the binding of myasthenia gravis antibody to acetylcholine receptor.The main immunogenic region of the acetylcholine receptor. Structure and role in myasthenia gravis.Autoimmune and paraneoplastic channelopathies.Muscle and neuronal nicotinic acetylcholine receptors. Structure, function and pathogenicity.Experimental autoimmune myasthenia gravis.How myasthenia gravis alters the safety factor for neuromuscular transmission.MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4.Anti-acetylcholine receptor antibodies directed against the alpha-bungarotoxin binding site induce a unique form of experimental myasthenia.Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.The pathogenesis of myasthenia gravis.Neuromuscular transmission failure in myasthenia gravis: decrement of safety factor and susceptibility of extraocular muscles.Pathogenic immune mechanisms at the neuromuscular synapse: the role of specific antibody-binding epitopes in myasthenia gravis.Humoral pathogenesis of myasthenia gravis.Immune regulation of experimental myastheniaAutoimmunity in neuromuscular disease.Monoclonal antibodies against defined determinants of acetylcholine receptor.Acetylcholine receptor antibodies in the diagnosis of human and experimental myasthenia gravis.Experimental models of myasthenia gravis: lessons in autoimmunity and progress toward better forms of treatment.Compromised fidelity of B-cell tolerance checkpoints in AChR and MuSK myasthenia gravis.Tirasemtiv amplifies skeletal muscle response to nerve activation in humansInterferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice.
P2860
Q28260224-71DB2A48-C517-430D-9946-25B55237A2D2Q30389491-E21DE7EB-DE04-4CE9-B690-6B60185B68EEQ33602986-22A9C00B-34DD-49D1-852C-69251E55972CQ33756375-04C94598-9FB6-4DB2-89C7-D9F7158EE92BQ33862589-4C614519-D028-4BAD-B55E-52DEEBE6ED9AQ33938477-DBD8E8E2-3A4D-42E2-9FB6-1578FF43B5AAQ33961390-F0ED762C-C939-41B1-A865-43D5C44E30A9Q34192385-C115E7C5-3D92-4BB1-AE94-79CB04524B58Q34233629-4E17A230-4158-4BDA-8426-A707DB7AD452Q34302653-D335B5D7-A9E4-4F91-A476-90DBC79C085FQ34860454-79D5A196-FF3A-4DEF-8187-6555D5A9739BQ35649128-335BD90E-49B2-471D-B5BF-B3D03E5EBBCAQ35738827-7D2AD5B2-CA20-46A0-9E5E-2D60C4A1A79FQ35818387-39BC9393-DA60-4CD9-A6B0-56B72B754F8EQ35831178-CC965096-D5EA-47E3-9495-14D29C9FAF9DQ35908826-1059E495-9975-42C8-9BF0-A22379FF2944Q36340160-2D4CC1A7-4E49-4F09-A242-43043934AD2EQ36355014-52EA4D3C-E4CA-4E49-B19E-C009C62CC3C8Q36359829-383AB41C-270F-48F1-BBA2-B0037BEC38A3Q36394830-DED7EC5C-B774-4FDB-8EFC-37BF6A3A2EF0Q36690423-203D104D-FCD9-4FB7-9C9D-F0B6C0AFDCEAQ36774744-115255B4-43FA-44C1-AF12-749D08A0A83FQ36890894-C1733E3A-BB18-4725-BD37-6D97E308D994Q37000263-ECB40861-1FF9-43A2-814E-AED8D242EF5BQ37106516-47723C79-A569-4471-8534-A59BB381A3C6Q37409458-47A9ED8C-96FB-4287-80CE-18C929DA4CFEQ37616547-8E88408C-0C4B-49ED-8E9C-2B38E450934CQ37727994-4F3C5DAE-5A6D-4812-8D08-EAFC78BF712CQ37797101-AFDFD05E-02A7-4634-92ED-C54BEB532795Q38070763-91897E46-C19B-45AD-BD20-9810318E3564Q38161532-59E8E372-9A12-458A-8B14-BBC4AB04E84FQ38182086-9F76989B-0A4E-46D3-91FA-0ACCBADBCBC2Q39237626-7B6F72E5-42C8-4E39-982C-EB119EB49074Q39302730-CEB7F4D2-02A7-4A4C-A41B-09B73C4C9C29Q39572617-5216C98D-5006-4EDE-B79B-114A72D586DEQ40471686-E7E7FD02-BE1A-4037-83B8-AC77A88A9696Q41517938-569B60DB-A033-44B3-A3EB-9061999F2BC4Q41893086-10DAA95A-1EBE-457E-B831-C0DC80FFDEC9Q42126154-2C0E521B-0C19-49A2-AF7E-A9C4D615A7B0Q42951672-C5E6938D-D71E-4C38-826A-F72FB9F9F7B7
P2860
Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies.
description
1976 nî lūn-bûn
@nan
1976年の論文
@ja
1976年学术文章
@wuu
1976年学术文章
@zh-cn
1976年学术文章
@zh-hans
1976年学术文章
@zh-my
1976年学术文章
@zh-sg
1976年學術文章
@yue
1976年學術文章
@zh
1976年學術文章
@zh-hant
name
Pathological mechanisms in exp ...... ylcholine recepotr antibodies.
@ast
Pathological mechanisms in exp ...... ylcholine recepotr antibodies.
@en
type
label
Pathological mechanisms in exp ...... ylcholine recepotr antibodies.
@ast
Pathological mechanisms in exp ...... ylcholine recepotr antibodies.
@en
prefLabel
Pathological mechanisms in exp ...... ylcholine recepotr antibodies.
@ast
Pathological mechanisms in exp ...... ylcholine recepotr antibodies.
@en
P2093
P2860
P356
P1476
Pathological mechanisms in exp ...... ylcholine recepotr antibodies.
@en
P2093
Lambert EH
Lindstrom JM
Seybold ME
P2860
P304
P356
10.1084/JEM.144.3.739
P407
P577
1976-09-01T00:00:00Z